HJMC
NVAX icon

Hellman Jordan Management Company’s Novavax NVAX Stock Holding History

Hellman Jordan Management Company’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,000
Closed -$1.11M – 61
2020
Q4 		$1.11M Sell
10,000
-40,910
-80% -$4.35M 3.54% 8
2020
Q3 		$5.52M Buy
+50,910
New +$6.2M 10.5% 5

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hellman Jordan Management Company's NVAX Position: Q1 2021 in Review

Hellman Jordan Management Company sold out of Novavax (NVAX) in Q1 2021, closing a stake of 10,000 shares — an estimated $1.11M sold.

Hellman Jordan Management Company first reported a position in NVAX in Q3 2020 and held it in 2 quarters. The position peaked at $5.52M in Q3 2020. 389 funds tracked by Wall St. Rank hold NVAX as of Q1 2021.

  • Hellman Jordan Management Company reported no remaining Novavax position as of Q1 2021 after selling out during the quarter.
  • Hellman Jordan Management Company sold 10,000 Novavax shares in Q1 2021, an estimated $1.11M.
  • Hellman Jordan Management Company first reported a position in Novavax in Q3 2020 and held it in 2 quarters.
  • Hellman Jordan Management Company's Novavax position peaked at $5.52M in Q3 2020.
  • 389 funds tracked by Wall St. Rank held Novavax as of Q1 2021.

Based on Hellman Jordan Management Company's 13F filing for Q1 2021, filed 6 May 2021.